Detection of p53 mutation and serum monitoring alert caused by Marek's disease virus

Huixia Zhang, Mengda Liu, Shengliang Cao, Yue Li, Shengnan Jiang, Yinuo Song, Sidang LiuResearch 2020 · DOI

Abstract

Marek’s disease (MD) is a neoplastic disease in chickens causing significant economic losses to the global poultry industry. This study investigates the role of the p53 tumor suppressor gene in MD pathogenesis. Results show a 60% mutation rate in p53 among infected chickens, primarily within the DNA-binding domain. These mutations lead to cytoplasmic accumulation of P53 protein and altered serum levels of P53 antigen and antibodies, suggesting potential for new diagnostic monitoring strategies.

Introduction

Marek’s disease (MD), caused by Marek’s disease virus (MDV), is a major challenge for the poultry sector, leading to tumor formation, paralysis, and immunosuppression. The p53 gene is a critical regulator that prevents cancer by managing the cell cycle and apoptosis. However, mutations can transform p53 from a tumor suppressor into an oncogene, significantly increasing cancer risk. This study explores the frequency and nature of p53 mutations in MD-infected chickens and evaluates serum P53 profiles as a potential diagnostic biomarker.

Methods

The researchers utilized SPF (Specific Pathogen Free) chickens for experimental infection and collected samples from naturally infected clinical cases. RNA was extracted from liver and spleen tissues to analyze the p53 gene. RT-PCR was employed to amplify the p53 DNA-binding domain (DBD) using specific primers and optimized annealing conditions.

Primer sequences and PCR conditions used for p53 amplification.

Histopathological analysis and immunohistochemistry (IHC) were performed to assess tumor growth and protein localization within tissues. Additionally, serum levels of P53 antigen and antibodies were measured via Enzyme-linked immunosorbent assays (ELISA) to identify systemic markers of infection.

Results

A high mutation rate of 60% (12 out of 20 infected birds) was observed in the p53 gene. These mutations included both point mutations and deletions, predominantly located in the core DNA-binding domain.

Detailed mutation analysis of p53 in MD-infected chickens, showing base and amino acid changes.

Key mutation hotspots were identified at five specific base sites: 651, 786, 828, 864, and 879. Unlike wild-type P53, which is nuclear and degrades rapidly (20–30 minutes), the mutated P53 proteins exhibited a loss of nuclear localization function. This led to significant accumulation in the cytoplasm and a greatly extended half-life of 20–40 hours.

Serological analysis revealed a significant inverse relationship: MD infection led to a decrease in serum P53 antigen levels while triggering a marked increase in P53 antibody titers ($p < 0.01$). This suggests the host immune system mounts a response against the abnormal, accumulated mutant proteins.

Discussion and Conclusion

The study confirms that p53 mutations are a common feature of Marek's disease and likely contribute to its oncogenic progression. The shift of P53 expression to the cytoplasm and the resulting changes in serum antibody profiles provide a promising avenue for MD diagnosis and flock health monitoring. Future research should focus on the specific molecular interactions between MDV genes, such as Meq, and the p53 pathway to fully elucidate the mechanism of viral-induced oncogenesis.

Summary updated

Abstract

Abstract Background Marek’s disease (MD), as a chicken neoplastic disease, brings huge economic losses to the global poultry industry. The tumor suppressor gene, wild type P53 plays a key role in blocking cell cycle, promoting apoptosis and maintaining stability of genome. The p53 function could change to that of an oncogene from a tumor inhibitory role, if a mutation happened. It will increase risk of cancer incidence. Results It was found that the mutation rate of p53 was 60 percent in experimentally infected and naturally infected chickens. The mutations included point-mutation and deletions, and mostly located in the DNA-binding domain. The most common point mutation happened in five sites, which were 651, 786, 828, 864 and 879 respectively. The mutated P53 can be expressed in tumors of various tissues in an infected chicken because of the lengthening of the half-life of mutated P53. Due to the loss of nuclear localization function, most of mutated P53 were expressed in cytoplasm. The concentration of P53 was decrease in serum of MD infected chicken. Conclusions Results of the current study suggested that p53 mutations with different types were common in MD, and most of mutated P53 were expressed in cytoplasm. Detecting the concertation of P53 and P53 antibody in serum could be helpful for diagnosis and monitor of MD.
BibTeX
@inproceedings{zhang2020detection,
  author = {Huixia Zhang and Mengda Liu and Hui Zhang and Shengliang Cao and Yue Li and Shengnan Jiang and Yinuo Song and Sidang Liu},
  title = {{Detection of p53 mutation and serum monitoring alert caused by Marek's disease virus}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.2.23898/v1},
}
Figure